Diagenode is a leading global provider of complete solutions for epigenetics research, biological sample preparation, and diagnostics assays based in Liège, Belgium and Denville, NJ, USA. The company has developed both shearing solutions for a number of applications as well as a comprehensive approach to gain new insights into epigenetic studies. The company offers innovative Bioruptor® shearing and IP-Star® automation instruments, reagent kits, and high quality antibodies to streamline DNA methylation, ChIP, and ChIP-seq workflows. The company's latest innovations include a unique, full automation system, the industry's most validated antibodies including Premium antibodies® and Blueprint antibodies™, and the Megaruptor shearing system for long fragment generation in sequencing.
From Diagenode's founding in 2003 in Liège as a local biotechnology startup, the company has expanded rapidly. Diagenode has opened its US branch in 2006 and developed a global distribution and partnering network including relationships in Japan and other Asia-Pacific countries. Diagenode has been profitable since its inception. The company planned to extensively develop its range of innovative products in both epigenetics and infectious diseases markets.
© Alain Janssens | www.delgoffe-architecture.be
Epigenetics is playing a revolutionary role in life sciences research. Rapid progress in this field is driving the need for new kinds of research tools and new standards for understanding the epigenetic control mechanisms involved in various biological phenomena such as disease development and drug mechanisms of action. Genome-wide tools such as Next Generation Sequencing that can assess global epigenetic changes at the histone or the DNA level dramatically advance understanding of the epigenetic mechanisms. Epigenetics research will identify new biomarkers for earlier-stage disease diagnosis and enable development of effective new therapeutics.
Epigenetic assays are complex and necessitate high-quality reagents, robust protocols, and comprehensive data analysis. Diagenode continually innovates solutions and provides the highest quality epigenetics tools available.
Our goal is to develop cutting-edge products that advance research in the rapidly evolving field of epigenetics. The company actively develops and markets a comprehensive portfolio of proprietary products that offers complete solutions for epigenetics-related research. Diagenode's Bioruptor® Sonicator is a best-in-class instrument series which provides unrivaled performance, durability, and value for shearing a wide spectrum of biological samples. Diagenode also specializes in offering a complete range of chromatin immunoprecipitation (ChIP) and DNA methylation products. The SX-8G IP-Star® Compact Automated Sytem represents the first complete system to automate ChIP and DNA methylation assays.
Shearing devices for DNA and chromatin preparation with a flexible range between 150 bp-75kb
Automated systems for ChIP and Library preparation for unmatched reproducibility with the IP-Star® Compact Automated System; includes protocols for high throughput and robust ChIP, MeDIP, MBD assays and NGS library preparation
Full range of ChIP and ChIP-seq kits
Epigenetics-focused antibodies for a wide range of targets including thoroughly validated ChIP/ChIP-seq-grade antibodies
Full DNA methylation solution including MeDIP, MBD, and bisulfite solutions
Next Generation Sequencing library preparation kits for inputs down to 50 pg
The field of human disease diagnostics is also changing and growing at a rapid rate. Diagenode offers amplification and quantification methods for DNA targets of human infectious disease. We also provide guidance to diagnostics companies developing epigenetics-based diagnostics. Our products are designed to make diagnostic assays simpler, faster, and more convenient, with the highest levels of quality. Our kits are CE-marked and certified ISO 9001 and ISO 13485.
For more information about our company, products, please contact us: